Wettstein J G, Spealman R D
J Pharmacol Exp Ther. 1986 Aug;238(2):522-8.
The effects of zopiclone, CL 218,872 and diazepam were compared in squirrel monkeys trained to respond under a fixed-interval (FI) schedule of food presentation. Dose-response curves were determined for each drug by administering cumulative doses i.v. during timeout periods that preceded sequential components of the FI schedule. Low and intermediate doses of zopiclone (0.03-1.0 mg/kg), CL 218,872 (0.3-3.0 mg/kg) or diazepam (0.1-1.0 mg/kg) produced dose-related increases in the rate of FI responding. The highest doses of diazepam (10.0 mg/kg) and CL 218,872 (30.0 mg/kg), but not of zopiclone (30.0 mg/kg), decreased FI responding markedly. Doses of zopiclone, CL 218,872 and diazepam that were effective in increasing FI responding were similar to the doses reported previously to increase suppressed (punished) responding in squirrel monkeys. Pretreatment with the benzodiazepine antagonists Ro 15-1788 or CGS 8216 (1.0 or 3.0 mg/kg) reduced or eliminated the increases in FI responding produced normally by intermediate doses of zopiclone, CL 218,872 or diazepam, suggesting that the rate-increasing effects of the three agonists reflect similar actions at benzodiazepine recognition sites. In contrast, Ro 15-1788 and CGS 8216 were less effective or ineffective in attenuating the marked decreases in FI responding produced by the highest doses of CL 218,872 or diazepam, suggesting that the rate-decreasing effects of these agonists are mediated differently from their rate-increasing effects.
在经过训练按固定间隔(FI)进食时间表做出反应的松鼠猴中,比较了佐匹克隆、CL 218,872和地西泮的作用。通过在FI时间表的连续成分之前的超时期间静脉注射累积剂量来确定每种药物的剂量-反应曲线。低剂量和中等剂量的佐匹克隆(0.03 - 1.0毫克/千克)、CL 218,872(0.3 - 3.0毫克/千克)或地西泮(0.1 - 1.0毫克/千克)使FI反应率产生剂量相关的增加。地西泮的最高剂量(10.0毫克/千克)和CL 218,872(30.0毫克/千克),但佐匹克隆的最高剂量(30.0毫克/千克)未出现此情况,显著降低了FI反应。在增加FI反应方面有效的佐匹克隆、CL 218,872和地西泮的剂量与先前报道的在松鼠猴中增加受抑制(受惩罚)反应的剂量相似。用苯二氮䓬拮抗剂Ro 15 - 1788或CGS 8216(1.0或3.0毫克/千克)预处理可减少或消除中等剂量的佐匹克隆、CL 218,872或地西泮通常产生的FI反应增加,这表明三种激动剂的速率增加作用反映了在苯二氮䓬识别位点的相似作用。相比之下,Ro 15 - 1788和CGS 8216在减弱CL 218,872或地西泮最高剂量产生的FI反应显著降低方面效果较差或无效,这表明这些激动剂的速率降低作用的介导方式与其速率增加作用不同。